Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)

Human Brain Mapping

Volumn 14, Issue 3, 2001, Pages 152-165

  Frei, Edi ^a   Gamma, Alex ^a   Pascual Marqui, Roberto ^a   Lehmann, Dietrich ^a   Hell, Daniel ^a   Vollenweider, Franz X ^a,b  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b Clinic for Affective Disorders   (Switzerland)

Author keywords

3,4 methylenedioxymethamphetamine (MDMA); Ecstasy; EEG; Emotion; Human; LORETA; Mood; Power spectrum; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CICLOPRAMINE; DEXAMPHETAMINE; DEXFENFLURAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; SEROTONIN; SEROTONIN AGONIST; TANDAMINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN MAPPING; BRAIN TOMOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABUSE; ELECTRODE; ELECTROENCEPHALOGRAM; EMOTION; HUMAN; HUMAN EXPERIMENT; LOW RESOLUTION BRAIN ELECTROMAGNETIC TOMOGRAPHY; MOOD; NERVE CELL; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCALP;

ACTION POTENTIALS; ADULT; AFFECT; BRAIN MAPPING; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; ELECTROMAGNETICS; EUPHORIA; FEMALE; FUNCTIONAL LATERALITY; HALLUCINOGENS; HUMANS; LIMBIC SYSTEM; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROTRANSMITTER AGENTS; PHOTIC STIMULATION; RECEPTORS, NEUROTRANSMITTER; SENSORY DEPRIVATION; VISUAL PERCEPTION;

EID: 0034761104     PISSN: 10659471     EISSN: None     Source Type: Journal    
DOI: 10.1002/hbm.1049     Document Type: Article

References (59)

1. Anderer P, Pascual-Marqui RD, Semlitsch HV, Saletu B (1998): Differential effects of normal aging on sources of standard N1, target N1, and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA). Electroenceph Clin Neurophysiol 108:160-74.
2. Anderer P, Saletu B, Pascual-Marqui RD (2000): Effect of the 5-HT1A partial agonist buspirone on regional brain electrical activity in man: a functional neuroimaging study using low-resolution electromagnetic tomography (LORETA). Psychiatry Res Neuroimaging 100:81-96.
3. Battaglia G, Brooks BP, Kulsakdinum C, De Souza EB (1988): Pharmacologic profile of MDMA (3,4-methyldenedioxymethamphetamine) at various brain recognition sites. Eur J Pharmacol 149: 159-163.
4. Bond AJ, Feizollah S, Lader MH (1995): The effects of d-fenfluramine on mood and performance, and on neuroendocrine indicators of 5-HT function. J Psychopharmacol 9:1-8.
5. Bouyer JJ, Montaron MF, Vahnee JM, Albert MP, Rougeul A (1987): Anatomical localization of cortical beta rhythms in cat. Neuroscience 22:863-869.
6. Brillinger DR (1981): Time series: data analysis and theory. New York: McGraw-Hill.
7. Brothers L (1996): Brain mechanisms of social cognition. J Psychopharmacol 10:2-8.
8. Cook EH Jr, Metz J, Leventhal BL, Lebovitz M, Nathan M, Semerdjian SA, Brown T, Cooper MD 1994. Fluoxetine effects on cerebral glucose metabolism. NeuroReport 5:1745-1748.
9. Cooley JW, Lewis PAW, Welch PD (1977): The fast Fourier transform and its application to time series analysis. In: Enslein K, Ralston A, Wilf HS, editors. Statistical methods for digital computers. New York: Wiley. p 377-423.
10. Deakin JFW (1996): 5-HT, antidepressant drugs and the psychosocial origins of depression. J Psychopharmacol 10:31-38.
11. Dittrich A (1996): Ätiologie-unabhängige Strukturen veränderter Wachbewusstseinszustände. Stuttgart: VWB-Verlag für Wissenschaft und Bildung.
12. Dittrich A (1998): The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 31:80-84.
13. Dittrich A, von Arx S, Staub S (1985): International study on altered states of consciousness (ISASC). Summary of the results. Germ J Psych 9:319-339.
14. Dittrich A, von Arx S, Staub S (1981): International study on altered states of consciousness (ISASC). Schweiz Z Psychol und Anw 40:189-200.
15. Fink M, Shapiro DM, Ith TM (1971): EEG profiles of fenfluramine, amobarbital and dextroamphetamine in normal volunteers. Psychopharmacology 22:369-383.
16. Fisher-Williams M (1993): Brain tumors and other space-occupying lesions. In: Niedermeyer E, Lopes da Silva FH, editors. Electroencephalography. Basic principles, clinical applications and related fields. Baltimore: Williams and Wilkins. p 263-289.
17. Gamma A, Frei E. Lehmann D, Pascual-Marqui RD, Hell C, Vollenweider FX (2000): Mood state and brain electric activity in Ecstasy users. Neuroreport 11:157-162.
18. Gouzoulis-Mayfrank E, Schneider F, Friedrich J, Spitzer M, Thelen B, Sass H (1999): Methodological issues of human experimental research with hallucinogens. Pharmacopsychiatry 31:114-118.
19. Gouzoulis-Mayfrank E, Habermeyer E, Hermle L, Steinmeyer AM, Kunert HJ, Sass H (1998): Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study. Eur Psychiatry 13:399-406.
20. Green AR, Cross AJ, Goodwin GM (1996): Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxydmethamphetamine (MDMA of "Ecstasy"). Psychopharmacology 119: 247-260.
21. Greer G, Tolbert R (1986): Subjective reports on the effects of MDMA in a clinical setting. J Psychoactive Drugs 18:319-327.
22. Heller W, Nitschke JB, Etienne MA, Miller GA (1997): Patterns of regional brain activity differentiate types of anxiety. J Abnorm Psychol 3:376-385.
23. Holmes AP, Blair RC, Watson JDG, Ford I (1996): Nonparametric analysis of statistic images from functional mapping experiments. J Cereb Blood Flow Metab 16:7-22.
24. Ishii R, Shinosaki K, Ukai S, Inouye T, Ishihara T, Yoshimine T, Hirabuki N, Asada H, Kihara T, Robinson SE, Takeda M (1999): Medial prefrontal cortex generates frontal midline theta rhythm. Neuroreport 10:675-679.
25. Janke W, Debus G (1978): Die Eigenschaftswörterliste (EWL-K)-Ein Verfahren zur Erfassung der Befindlichkeit. Göttingen: Hogrefe.
26. Kounios J, Smith RW, Yang W, Bachman P, Desposito M (2001): Cognitive association formation in human memory revealed by spatiotemporal brain imaging. Neuron 29:297-306.
27. Kiroy VN, Warsawskaya LV, Voynov VB (1996): EEG after prolonged mental activity. Int J Neuroscience 85:31-43.
28. Kubicki S, Herrmann WM, Fichte K, Freund G (1979): Reflections on the topics: EEG frequency bands and regulation of vigilance. Pharmakopsychiatr Neuropsychopharmakol 12:237-245.
29. Le Doux JE (1991): Emotion and the limbic system concept. Concepts Neurosci 2:169-199.
30. Lehrl S, Kinzel W, Fischer B, Weidenhammer W (1986): Psychiatrische und medizinpsychologische Messverfahren des deutschsprachigen Raumes, 1 edn. Vless Verlag, Ebersberg.
31. Leuner H (1981): Halluzinogene: Psychische Grenzzustände in Forschung und Therapie. Bern: Hans Huber.
32. Liechti ME, Baumann C, Gamma A, Vollenweider FX (2000): Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22:513-521.
33. Lopes da Silva FH, van Rotterdam A, Storm van Leeuwen W, Tielen AM (1970): Dynamic characteristics of visual evoked potentials in the dog. II. Beta frequency selectivity in evoked potentials and background activity. Electroencephalogr Clin Neurophysiol 29: 260-268.
34. Lukas SE, Mendelson JH, Amass L, Benedikt R (1989): Behavioral and EEG studies of acute cocaine administration: comparisons with morphine, amphetamine, pentobarbital, nicotine, ethanol and marijuana. NIDA Res Monogr 95:146-151.
35. Lukas SE, Mendelson JH, Benedikt R (1995): Electroencephalographic correlates of marihuana-induced euphoria. Drug Alcohol Depend 37:131-140.
36. Mesulam M (1990): Large-scale neurocognitive networks and distributed processing for attention, language and memory. Ann Neurol 28:597-613.
37. Mizuki Y, Kajimura N, Kai S, Suetsugi M, Ushijima I, Yamada M (1992): Differential responses to mental stress in high and low anxious normal humans assessed by frontal midline theta activity. Int J Psychophysiol 12:169-178.
38. Murthy VN, Fetz EE (1992): Coherent 25- to 35-Hz oscillations in the sensorimotor cortex of awake behaving monkeys. Proc Natl Acad Sci USA 89:5670-5674.
39. Niedermeyer E (1997): Alpha rhythms as physiological and abnormal phenomena. Int J Psychophysiol 26:31-49.
40. Pascual-Marqui RD, Michel CM, Lehmann D (1994): Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int J Psychophysiol 18:49-65.
41. Pascual-Marqui RD (1999): Review of methods for solving the EEG inverse problem. Int J Bioelectromag 1:75-86.
42. Pascual-Marqui RD, Lehmann D, Koenig T, Kochi K, Merlo MC, Hell D, Koukkou M (1999): Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naïve, first-episode, productive schizophrenia. Psychiatry Res Neuroimaging 90:169-179.
43. Pizzagalli D, Pascual-Marqui RD, Larson CL, Nitschke JB, Oakes TR, Abercrombie HC, Schaefer SM, Koger JV, Benca RM, Davidson RJ (2001): Anterior cingulate activity predicts degree of treatment response in major depression: evidence from brain electric tomography analysis. Am J Psychiatry 158:405-415.
44. Rougeul-Buser A, Bouyer JJ, Montaron MF, Buser P (1983): Patterns of activities in the ventrobasal thalamus and somatic cortex SI during behavioral immobility in the awake cat: focal waking rhythms. Exp Brain Res 7(Suppl):69-87.
45. Saletu B (1982): Pharmaco-EEG profiles of typical and atypical antidepressants. Adv Biochem Psychopharmacol 32:257-268.
46. Saletu B, Barbanoj MJ, Anderer P, Sieghart W, Grunberger J (1993): Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation. Methods Find Exp Clin Pharmacol 15:291-312.
47. Saletu B, Gruenberger J, Anderer P, Linzmayer L, Zyhlarz G (1996): Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry. J Neural Transm 103: 191-216.
48. Saletu B, Gruenberger J, Linzmayer L (1980): Is amezinium metilsulfate - a new antihypotensive drug - psychoactive? Comparative quantitative EEG and psychometric trials with desipramine and methamphetamine. Curr Ther Res 28:800-826.
49. Seeck M, Lazeyras F, Michel CM, Blanke O, Gericke CA, Ives J, Delavelle J, Golay X, Haenggeli CA, de Tribolet N, Landis T (1998): Non-invasive epileptic focus localization using EEG-triggered functional MRI and electromagnetic tomography. Electroenceph Clin Neurophysiol 106:508-512.
50. Sharbrough FW (1993): Nonspecific abnormal EEG patterns. In: Niedermeyer E, Lopes da Silva FH, editors. Electroencephalography. Basic principles, clinical applications and related fields. Baltimore: Williams and Wilkins. p 197-215.
51. Sheer D (1984): Focused arousal, 40 Hz, and dysfunction. In: Ebert T, editor. Self-regulation of the brain and behavior. Berlin: Springer. p 64-84.
52. Silva LR, Amitai Y, Connors BW (1991): Intrinsic oscillations of neocortex generated by layer 5 pyramidal neurons. Science 251: 432-435.
53. Solowij N, Hall W, Lee N (1992): Recreational MDMA use in Sydney: a profile of 'Ecstasy' users and their experiences with the drug. Br J Addict 87:1161-1172.
54. Talairach J, Tournoux P (1988): Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme.
55. Towle VL, Bolanos J, Suarez D, Tan K, Grzeszczuk R, Levin DN, Cakmur R, Frank SA, Spire JP (1993): The spatial location of EEG electrodes: locating the best-fitting sphere relative to cortical anatomy. Electroencephalogr Clin Neurophysiol 86:1-6.
56. Vollenweider FX (1998): Advances and pathophysiological models of hallucinogen drug actions in humans: a preamble to schizophrenia research. Pharmacopsychiatry 31:92-103.
57. Vollenweider FX, Gamma A, Liechti M, Huber TH (1998): Psychological and cardiovascular effects and short-term sequelae of MDMA ('Ecstasy') on MDMA-naive healthy volunteers. Neuropsychopharmacology 19:241-251.
58. Worrell GA, Lagerlund TD, Sharbrough FW, Brinkmann BH, Busacker NE, Cicora KM, O'Brien TJ (2000): Localization of the epileptic focus by low-resolution electromagnetic tomography in patients with lesion demonstrated by MRI. Brain Topography 12:273-282.
59. Yamamoto BK, Spanos LJ (1988): The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol 148:195-203.